Amyris, Ipca Laboratories sign LOI for pharma ingredients
In California, Amyris and India’s Ipca Laboratories have signed a Letter of Intent (LOI) to establish an agreement for Amyris to supply a key starting material for an active pharmaceutical ingredient to Ipca. This initial ingredient is expected to enable Ipca to more reliably and cost effectively compete with other manufacturers in the production of […]









